Interview with Dr. Ted Dryja, Scientific Advisory Board member. The pioneer in inherited retinal diseases joined ProQR to help push the organization forward. “I'm excited about what RNA technology may do for ProQR’s ophthalmology pipeline."
ProQR has a promising pipeline in ophthalmology programs that is built on RNA technology. According to Dr. Peter Adamson, ProQR’s (former) Senior Vice President Ophthalmology Franchise, RNA may reach the ultimate goal: to make blind people see again.
… agreements. BOD support Acting as a liaison with the Board of Directors and investors. Work with external partners … Board of Directors meetings, Remuneration Committee, ScientificAdvisoryBoard meetings, Audit Committee meetings and …
